Testosterone is a reservoir of estradiol (E2)

madman

Super Moderator
Dr. Franck Mauvais-Jarvis another powerhouse in the field!



33:00-39:35


• Fundamental Knowledge for Sex-based Biology & Medicine - Lecture by Dr. Franck Mauvais-Jarvis





1794708301208.webp

1794708364886.webp
 
 
 
It's been a while since I posted anything on this excellent forum. Please advise if I should be doing something better. The issue of side effects in much of how we recommend or don't recommend something "begs the question." Let me explain. We are supposed to be cognitive beings. If a sign says "radioactive, keep out" we don't ignore this. If a treatment or a test can be misused or abused, then it is the folly (aka stupidity or ignorance) of those that proceed with the treatment or use the test results out of context that is operative. In other words, don't throw the baby out with the bath water. Some examples:
In my medical practice devoted to prostate cancer, I consulted on an 80-year old with a recent history of a PSA of 86 or something in the eighties. He was brought to my office by his daughter. A history of combativeness and physical abuse to the elderly man's wife was a key part of her concern. He had been seen by the chief of urology at a nearby major medical center. Despite presenting with a PSA in the 60's, and despite he being elderly and to my examination had Alzheimer’s disease with combative features, he was advised by the urologist to have an RP. He did and a few months after the RP his PSA was in the 40's. His workup prior to the RP was, in my opinion, incompetent. When seen by the same urologist, he was directed to the radiation oncologist for RT to his prostate. At that point the patient's daughter sought consultation with me. The THL (take home lesson) is we USE the PSA results in the context of the patient and not as a traffic light to stop or go. The same with any level of PSA. We use context of the patient's clinical situation with inputs of mental status, extent of disease (EOD) determined intelligently, and all other contextual issues addressed. This should be done at what I call a phenotypic level (patient exam, history, lab and imaging tests) and at a molecular level (PSA kinetics such as doubling time and velocity). In doing so, we profile the patient's biology, from the gross to the microscopic to the biomarkers available. In doing so, we aptly identify who needs to be treated and what options are in the patient's best interests. This way, we do not confuse the value of any test or treatment with how humans may abuse something. Exposure to sunlight can be beneficial but only with an understanding about too much or too little. The same with testosterone use. What's the big deal in getting periodic CBC, PSA or any other lab to monitor the biologic effects of what we do. Such feedback is how we learn from childhood to old age. What's the big deal?
 

ExcelMale Newsletter Signup

Beyond Testosterone Podcast

Online statistics

Members online
5
Guests online
958
Total visitors
963

Latest posts

Back
Top